(19)
(11)
EP 0 906 423 A1
(12)
(43)
Date of publication:
07.04.1999
Bulletin 1999/14
(21)
Application number:
97921662.0
(22)
Date of filing:
18.04.1997
(51)
International Patent Classification (IPC):
C07K
14/
47
( . )
C12N
15/
12
( . )
A61K
38/
00
( . )
C07K
16/
30
( . )
G01N
33/
574
( . )
(86)
International application number:
PCT/EP1997/001963
(87)
International publication number:
WO 1997/041221
(
06.11.1997
Gazette 1997/47)
(84)
Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
RO SI
(30)
Priority:
29.04.1996
US 19960016487P
28.02.1997
GB 19970004161
(71)
Applicant:
Novartis AG
4058 Basel (CH)
(72)
Inventors:
BACHMANN, Felix
CH-4052 Basel (CH)
BURGER, Max M.
CH-4103 Bottmingen (CH)
(74)
Representative:
Becker, Konrad, et al
Novartis AG Patent- und Markenabteilung CH Lichtstrasse 35
4002 Basel
4002 Basel (CH)
(54)
METASTASIS-ASSOCIATED ANTIGEN AND ANTIBODIES THERETO